| Literature DB >> 30608209 |
Arjen Mol1,2, Esmee M Reijnierse3, Marijke C Trappenburg4,5, Richard J A van Wezel2,6, Andrea B Maier1,3, Carel G M Meskers1,7.
Abstract
Background Orthostatic hypotension is a prevalent condition in older adults and is associated with impaired physical performance and falls. The ability of older adults to compensate for rapid changes in systolic blood pressure ( SBP ; ie, SBP decline rate and SBP variability) may be important for physical performance. This study investigates the association of rapid SBP changes after standing up with physical performance. Methods and Results Consecutive patients who visited the Center of Geriatrics Amsterdam in 2014 and 2015 were included. The following SBP parameters were computed in 2 intervals (0-15 and 15-180 seconds) after standing up: steepness of steepest SBP decline; ratio of standing/supine SBP variability; and magnitude of largest SBP decline. Physical performance was assessed using the following measures: chair stand time, timed up and go time, walking speed, handgrip strength, and tandem stance performance. A total of 109 patients (45% men; age, mean, 81.7 years [ standard deviation , 7.0 years]) were included. Steepness of steepest SBP decline (0-15 seconds) was associated with slower chair stand time ( P<0.001), timed up and go time ( P=0.022), and walking speed ( P=0.024). Ratio of standing/supine SBP variability (0-15 seconds) was associated with slower chair stand time ( P=0.005). Magnitude of largest SBP decline was not associated with physical performance. Conclusions SBP parameters reflecting rapid SBP changes were more strongly associated with physical performance compared with SBP decline magnitude in geriatric outpatients. These results support the hypothesis of an inadequate cerebral autoregulation during rapid SBP changes and advocate the use of continuous blood pressure measurements.Entities:
Keywords: cerebral autoregulation; continuous blood pressure measurement; geriatric assessment; orthostatic hypotension; physical performance
Mesh:
Year: 2018 PMID: 30608209 PMCID: PMC6404215 DOI: 10.1161/JAHA.118.010060
Source DB: PubMed Journal: J Am Heart Assoc ISSN: 2047-9980 Impact factor: 5.501
Figure 1Example of continuous systolic blood pressure (SBP) before, during, and after standing up in one patient. The interval from −67 to −7 seconds represents baseline (supine position), −7 to 0 seconds (gray shaded) represents the transition from supine to standing position, and 0 to 180 seconds represents the standing position period. SBP drop magnitude indicates the difference between baseline SBP (purple dotted line) and the lowest measured SBP value in the standing intervals (purple dashed lines) at 0–15 and 15–180 seconds; SBPmax drop rate, the steepness of the steepest negative tangent line (red lines) in the standing intervals (0–15 and 15–180 seconds); SBP variability, the SD of the difference between adjacent SBP values in the indicated intervals (0–15 and 15–180 seconds); SBP variability ratio, SBP variability in the standing intervals (0–15 and 15–180 seconds)/baseline variability.
Patient Characteristics
| Characteristics | N | Value for All (n=109) |
|---|---|---|
| Sociodemographics | ||
| Age, mean (SD), y | 109 | 81.7 (7.0) |
| Male sex, n (%) | 109 | 49 (45.0) |
| Living at home, n (%) | 105 | 90 (85.7) |
| Current smoking, n (%) | 103 | 13 (12.6) |
| Highly educated, n (%) | 105 | 18 (17.1) |
| Health characteristics | ||
| Excessive alcohol use, n (%) | 95 | 8 (8.4) |
| Multimorbidity, n (%) | 109 | 51 (46.8) |
| BMI, mean (SD), kg/m2 | 105 | 26.2 (7.5) |
| MMSE, median (IQR) | 100 | 27.0 (24.0–29.0) |
| No. of medications, median (IQR) | 104 | 7.0 (4.0–9.0) |
| Supine blood pressure, mean (SD), mm Hg | ||
| Systolic | 109 | 132.7 (27.0) |
| Diastolic | 109 | 68.6 (11.2) |
| Orthostatic BP and HR responses | ||
| OHintermittently, n (%) | 73 | 30 (41.1) |
| OHcontinuously, n (%) | 109 | 83 (76.1) |
| iOH, n (%) | 109 | 32 (29.4) |
| SBPmax drop rate, 0–15, median (IQR), mm Hg/s | 109 | −2.53 (−4.97 to −0.86) |
| SBPmax drop rate, 15–180, median (IQR), mm Hg/d | 109 | −2.96 (−4.48 to −2.13) |
| SBPvariability ratio, 0–15, median (IQR) | 109 | 1.03 (0.57–2.14) |
| SBPvariability ratio, 15–180, median (IQR) | 109 | 0.909 (0.51–1.35) |
| SBPdrop magnitude, 0–15, mean (SD), mm Hg | 109 | 27.6 (24.3) |
| SBPdrop magnitude, 15–180, mean (SD), mm Hg | 109 | 26.4 (31.3) |
| HR increase 0 to 180 s in 1/s, median (IQR) | 109 | 23.9 (11.28–29.4) |
| Physical performance | ||
| CST, median (IQR), s | 79 | 13.7 (10.9–17.8) |
| TUG, median (IQR), s | 68 | 15.0 (11.1–18.0) |
| Walking speed on 4‐m walk test, mean (SD), m/s | 99 | 0.80 (0.32) |
| HGS in men, mean (SD), kg | 44 | 26.0 (8.7) |
| HGS in women, mean (SD), kg | 52 | 13.3 (7.1) |
| Side‐by‐side stance, able to maintain, n (%) | 101 | 90 (89.1) |
| Semitandem stance, able to maintain, n (%) | 101 | 77 (76.2) |
| Tandem stance, able to maintain, n (%) | 100 | 37 (37.0) |
BMI indicates body mass index; BP, blood pressure; CST, chair stand time; HGS, handgrip strength; HR, heart rate; iOH, initial OH; IQR, interquartile range; MMSE, Mini‐Mental State Examination; OH, orthostatic hypotension; OHintermittently/OHcontinuously, prevalence of OH assessed using intermittent/continuous BP measurements; SBP, systolic blood pressure; SBPdrop magnitude, the difference between baseline SBP and the lowest measured SBP value in the standing intervals at 0–15 and 15–180 seconds; SBPmax drop rate, the steepness of the steepest negative tangent line in the standing intervals (0–15 and 15–180 seconds); SBPvariability ratio, the variability in the standing intervals (0‐15 and 15‐180 seconds)/baseline variability; TUG, timed up and go time.
Highly educated is defined as having a university degree.
Excessive alcohol use is defined as >14 units per week for women and >21 units per week for men.
Multimorbidity is defined as ≥ 2 diseases of the following: chronic obstructive pulmonary disease, diabetes mellitus, hypertension, malignancy, myocardial infarction, Parkinson disease, or rheumatoid/(osteo)arthritis.
Continuously measured.
Continuously Measured BP and Physical Performance
| Variable | Dynamic Physical Performance | Static Physical Performance | |||
|---|---|---|---|---|---|
| logCST, s (n=79) | logTUG, s (n=68) | Walking Speed, m/s (n=99) | HGS, kg (n=96) | Tandem Stance, % Able (n=100) | |
| SBPmax drop rate, 0–15 | |||||
| β/OR | 0.177 (β) | 0.105 (β) | −0.066 (β) | 0.123 (β) | 0.603 (OR) |
| 95% CI | 0.085 to 0.269 | 0.016 to 0.195 | −0.123 to −0.009 | −1.330 to 1.575 | 0.186 to 1.957 |
|
| <0.001 | 0.022 | 0.024 | 0.876 | 0.400 |
| SBPvariability ratio, 0–15 | |||||
| β/OR | 0.121 (β) | 0.069 (β) | −0.010 (β) | −0.107 (β) | 0.971 (OR) |
| 95% CI | 0.038 to 0.205 | −0.017 to 0.155 | −0.069 to 0.048 | −1.504 to 1.290 | 0.632 to 1.491 |
|
| 0.005 | 0.112 | 0.726 | 0.879 | 0.893 |
| SBPdrop magnitude, 0–15 | |||||
| β/OR | 0.032 (β) | −0.007 (β) | 0.005 (β) | −0.109 (β) | 0.627 (OR) |
| 95% CI | −0.072 to 0.136 | −0.105 to 0.091 | −0.054 to 0.064 | −1.643 to 1.425 | 0.196 to 2.010 |
|
| 0.538 | 0.887 | 0.876 | 0.888 | 0.433 |
| SBPmax drop rate, 15–180 | |||||
| β/OR | −0.011 (β) | −0.011 (β) | 0.002 (β) | 0.348 (β) | 0.634 (OR) |
| 95% CI | −0.106 to 0.084 | −0.097 to 0.075 | −0.055 to 0.060 | −1.051 to 1.820 | 0.198 to 2.029 |
|
| 0.818 | 0.797 | 0.935 | 0.596 | 0.443 |
| SBPvariability ratio, 15–180 | |||||
| β/OR | 0.003 (β) | −0.023 (β) | 0.029 (β) | 0.951 (β) | 0.694 (OR) |
| 95% CI | −0.094 to 0.099 | −0.110 to 0.064 | −0.030 to 0.088 | −0.524 to 2.425 | 0.412 to 1.169 |
|
| 0.953 | 0.598 | 0.336 | 0.204 | 0.169 |
| SBPdrop magnitude, 15–180 | |||||
| β/OR | 0.044 (β) | −0.013 (β) | −0.029 (β) | −1.632 (β) | 1.182 (OR) |
| 95% CI | −0.077 to 0.165 | −0.129 to 0.102 | −0.096 to 0.039 | −3.525 to 0.106 | 0.730 to 1.915 |
|
| 0.475 | 0.819 | 0.404 | 0.065 | 0.497 |
SBPmax drop rate, SBPvariability ratio, and SBPdrop magnitude were normalized to enable comparing β values/ORs. CST, TUG, walking speed, and HGS data are from linear regression analyses, with adjustments for age, sex, height, and weight; and they are reported using regression β values. Balance data are from logistic regression analyses with adjustments for the same factors and reported using ORs. BP indicates blood pressure; CI, confidence interval; HGS, handgrip strength; logCST, logarithm of chair stand time (in seconds); logTUG, logarithm of timed up and go time (in seconds); OR, odds ratio; SBP, systolic blood pressure; SBPdrop magnitude, the difference between baseline SBP and the lowest measured SBP value in the standing intervals at 0–15 and 15–180 seconds; SBPmax drop rate, the steepness of the steepest negative tangent line in the standing intervals (0–15 and 15–180 seconds); SBPvariability ratio, the variability in the standing intervals (0–15 and 15–180 seconds)/baseline variability.
This association does not remain significant after correction for multiple comparisons.
This association remains significant after correction for multiple comparisons.
Maximum HR Increase After Standing Up and SBP Parameters
| Variable | logSBPmax drop rate, mm Hg/s (n=109) | logSBPvariability ratio (n=109) | SBPdrop magnitude, mm Hg (n=109) |
|---|---|---|---|
| HRincrease, 0–180 | 0 to 15 s | ||
| β | 0.018 | 0.014 | 0.112 |
| 95% CI | −0.027 to 0.063 | 0.005 to 0.022 | −0.086 to 0.310 |
|
| 0.428 | 0.003 | 0.264 |
| HRincrease, 0–180 | 15 to 180 s | ||
| β | 0.008 | 0.010 | 0.135 |
| 95% CI | 0.003 to 0.012 | 0.004 to 0.017 | −0.122 to 0.392 |
|
| 0.002 | 0.002 | 0.301 |
SBPmax drop rate and SBPvariability ratio were log transformed to obtain normal distributions. All data are from linear regression analyses. CI indicates confidence interval; HR, heart rate; HRincrease, 0–180, maximum increase of HR within 180 seconds after standing up compared with baseline; SBP, systolic blood pressure; SBPdrop magnitude, magnitude of largest SBP decline; SBPmax drop rate, steepness of steepest SBP decline; SBPvariability ratio, ratio of standing/supine SBP variability.
P < 0.05.
Maximum HR Increase After Standing Up and Physical Performance
| Variable | Dynamic Physical Performance | Static Physical Performance | |||
|---|---|---|---|---|---|
| logCST, s (n=79) | logTUG, s (n=68) | Walking Speed, m/s (n=99) | HGS, kg (n=96) | Tandem Stance, % Able (n=100) | |
| HRincrease, 0–180 | |||||
| β/OR | 0.003 (β) | 0.003 (β) | −0.001 (β) | −0.040 (β) | 0.994 (OR) |
| 95% CI | −0.001 to 0.006 | −0.001 to 0.007 | −0.003 to 0.002 | −0.126 to 0.045 | 0.975 to 1.014 |
|
| 0.166 | 0.164 | 0.635 | 0.355 | 0.576 |
CST, TUG, walking speed, and HGS data are from linear regression analyses. Tandem stance data are from logistic regression analyses. CI indicates confidence interval; HGS, handgrip strength; HR, heart rate; HRincrease, 0–180, maximum increase of HR within 180 seconds after standing up compared with baseline; logCST, logarithm of chair stand time (in seconds); logTUG, logarithm of timed up and go time (in seconds); OR, odds ratio.
Continuously Measured BP and Physical Performance, Adjusted for Baroreflex Function
| Variable | Dynamic Physical Performance | Static Physical Performance | |||
|---|---|---|---|---|---|
| logCST, s (n=79) | logTUG, s (n=68) | Walking Speed, m/s (n=99) | HGS, kg (n=96) | Tandem Stance, % Able (n=100) | |
| SBPmax drop rate, 0–15 | |||||
| β/OR | 0.168 (β) | 0.099 (β) | −0.065 (β) | 0.185 (β) | 1.026 (OR) |
| 95% CI | 0.075 to 0.262 | 0.006 to 0.191 | −0.124 to −0.007 | −1.294 to 1.664 | 0.620 to 1.697 |
|
| 0.001 | 0.037 | 0.029 | 0.804 | 0.921 |
| SBPvariability ratio, 0–15 | |||||
| β/OR | 0.110 (β) | 0.059 (β) | −0.007 (β) | 0.016 (β) | 1.026 (OR) |
| 95% CI | 0.022 to 0.198 | −0.034 to 0.152 | −0.068 to 0.055 | −1.448 to 1.479 | 0.647 to 1.626 |
|
| 0.015 | 0.208 | 0.834 | 0.983 | 0.914 |
| SBPdrop magnitude, 0–15 | |||||
| β/OR | 0.031 (β) | −0.013 (β) | 0.006 (β) | −0.091 (β) | 1.154 (OR) |
| 95% CI | −0.072 to 0.134 | −0.112 to 0.085 | −0.054 to 0.065 | −1.634 to 1.452 | 0.704 to 1.891 |
|
| 0.555 | 0.785 | 0.843 | 0.907 | 0.570 |
| SBPmax drop rate, 15–180 | |||||
| β/OR | 0.038 (β) | −0.042 (β) | 0.007 (β) | 0.585 (β) | 0.796 (OR) |
| 95% CI | −0.151 to 0.053 | −0.139 to 0.054 | −0.055 to 0.060 | −0.960 to 2.129 | 0.466 to 1.360 |
|
| 0.526 | 0.386 | 0.771 | 0.454 | 0.403 |
| SBPvariability ratio, 15–180 | |||||
| β/OR | −0.033 (β) | −0.059 (β) | 0.041 (β) | 1.276 (β) | 0.702 (OR) |
| 95% CI | −0.137 to 0.071 | −0.156 to 0.039 | −0.053 to 0.071 | −0.321 to 2.874 | 0.400 to 1.234 |
|
| 0.531 | 0.235 | 0.207 | 0.116 | 0.485 |
| SBPdrop magnitude, 15–180 | |||||
| β/OR | 0.035 (β) | −0.018 (β) | −0.027 (β) | −1.601 (β) | 0.986 (OR) |
| 95% CI | −0.082 to 0.159 | −0.133 to 0.098 | −0.096 to 0.041 | −3.344 to 0.141 | 0.562 to 1.728 |
|
| 0.499 | 0.760 | 0.432 | 0.071 | 0.961 |
SBPdrop rate, SBPvariability ratio, and SBPdrop magnitude were normalized to enable comparing β values/ORs. CST, TUG, walking speed, and HGS data are from linear regression analyses with adjustments for age, sex, height, weight, and maximum increase of heart rate within 180 seconds after standing up compared with baseline; they are reported using regression β values. Tandem stance data are from logistic regression analyses with adjustments for the same factors and reported using ORs. BP indicates blood pressure; CI, confidence interval; HGS, handgrip strength; logCST, logarithm of chair stand time (in seconds); logTUG, logarithm of timed up and go time (in seconds); OR, odds ratio; SBP, systolic blood pressure; SBPdrop magnitude, the difference between baseline SBP and the lowest measured SBP value in the standing intervals at 0–15 and 15–180 seconds; SBPmax drop rate, the steepness of the steepest negative tangent line in the standing intervals (0–15 and 15–180 seconds); SBPvariability ratio, the variability in the standing intervals (0–15 and 15–180 seconds)/baseline variability.
This association does not remain significant after correction for multiple comparisons.
This association remains significant after correction for multiple comparisons.